阻断-话题@MedSci

#阻断#

363篇内容 | 3036人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1710307, encodeId=72951e10307de, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Crit Care：急性呼吸窘迫综合征(ARDS)的COVID-19患者早期短疗程神经肌肉阻断剂的治疗效果, objectType=article, longId=727459, objectId=25c5e2745918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25c5e2745918, replyNumber=0, likeNumber=140, createdTime=2022-06-12, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25c5e2745918, moduleTitle=Crit Care：急性呼吸窘迫综合征(ARDS)的COVID-19患者早期短疗程神经肌肉阻断剂的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25c5e2745918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710308, encodeId=345c1e1030871, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=PLoS Pathog：I型干扰素或能在病毒感染期间阻断机体免疫系统的“失控”, objectType=article, longId=728111, objectId=610fe2811123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=610fe2811123, replyNumber=0, likeNumber=125, createdTime=2022-12-14, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=610fe2811123, moduleTitle=PLoS Pathog：I型干扰素或能在病毒感染期间阻断机体免疫系统的“失控”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=610fe2811123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710310, encodeId=6a541e1031039, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=ARD：关于在炎症条件下阻断白细胞介素6受体和白细胞介素6的共识声明：更新, objectType=article, longId=736301, objectId=0689e3630143, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0689e3630143, replyNumber=0, likeNumber=101, createdTime=2022-12-01, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0689e3630143, moduleTitle=ARD：关于在炎症条件下阻断白细胞介素6受体和白细胞介素6的共识声明：更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0689e3630143)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710299, encodeId=dbda1e1029935, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=磁珠肝门阻断小发明腔镜肝脏切除好助手, objectType=article, longId=291774, objectId=35a3291e743d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35a3291e743d, replyNumber=0, likeNumber=123, createdTime=2021-12-25, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35a3291e743d, moduleTitle=磁珠肝门阻断小发明腔镜肝脏切除好助手, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35a3291e743d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710300, encodeId=1b251e10300b6, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=J Clin Oncol：PD-1和CTLA-4双重阻断二线治疗晚期宫颈癌疗效显著, objectType=article, longId=292558, objectId=2c632925589c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c632925589c, replyNumber=0, likeNumber=118, createdTime=2022-09-13, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c632925589c, moduleTitle=J Clin Oncol：PD-1和CTLA-4双重阻断二线治疗晚期宫颈癌疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c632925589c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710309, encodeId=39921e10309c4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效, objectType=article, longId=728112, objectId=d043e28112d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d043e28112d0, replyNumber=0, likeNumber=128, createdTime=2022-08-18, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d043e28112d0, moduleTitle=Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d043e28112d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710306, encodeId=3ffd1e103069e, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=《细胞》子刊：内外夹击，效果更强！科学家揭示PD-1和TIGIT共同阻断疗法的抗癌机制，共同为CD226解围来激活T细胞抗癌功能, objectType=article, longId=302024, objectId=76f13020240e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76f13020240e, replyNumber=0, likeNumber=137, createdTime=2022-06-03, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76f13020240e, moduleTitle=《细胞》子刊：内外夹击，效果更强！科学家揭示PD-1和TIGIT共同阻断疗法的抗癌机制，共同为CD226解围来激活T细胞抗癌功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76f13020240e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710297, encodeId=f5031e102977b, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=2021年12月9日简报：全球奥密克戎变种亚型出现，难以被检测；辉瑞疫苗对奥密克戎阻断力下降41倍，美国加强针接种速度破记录, objectType=article, longId=221768, objectId=4eb0221e6868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eb0221e6868, replyNumber=0, likeNumber=104, createdTime=2022-07-24, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eb0221e6868, moduleTitle=2021年12月9日简报：全球奥密克戎变种亚型出现，难以被检测；辉瑞疫苗对奥密克戎阻断力下降41倍，美国加强针接种速度破记录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eb0221e6868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710304, encodeId=c5d51e10304eb, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Br J Dermatol：Brodaluma阻断 IL-17RA可减少化脓性汗腺炎皮肤和血清中的炎症通路, objectType=article, longId=300087, objectId=8e5930008e1a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5930008e1a, replyNumber=0, likeNumber=119, createdTime=2023-01-08, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5930008e1a, moduleTitle=Br J Dermatol：Brodaluma阻断 IL-17RA可减少化脓性汗腺炎皮肤和血清中的炎症通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5930008e1a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710302, encodeId=ff8e1e103020e, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Med：黑色素瘤患者与免疫检查点阻断毒性相关的T细胞特征, objectType=article, longId=293979, objectId=c08c2939e93e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c08c2939e93e, replyNumber=0, likeNumber=122, createdTime=2022-11-25, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c08c2939e93e, moduleTitle=Nat Med：黑色素瘤患者与免疫检查点阻断毒性相关的T细胞特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c08c2939e93e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710303, encodeId=cb4f1e103039b, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Commum：无惧突变，华人团队揭示外泌体可作为诱饵阻断多种新冠突变株, objectType=article, longId=294588, objectId=88922945884c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88922945884c, replyNumber=0, likeNumber=97, createdTime=2022-10-08, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88922945884c, moduleTitle=Nat Commum：无惧突变，华人团队揭示外泌体可作为诱饵阻断多种新冠突变株, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88922945884c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710301, encodeId=9bf51e103015e, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=J Urol：雄激素阻断治疗是否会导致痴呆？, objectType=article, longId=293235, objectId=10d2293235fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d2293235fd, replyNumber=0, likeNumber=100, createdTime=2022-01-14, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d2293235fd, moduleTitle=J Urol：雄激素阻断治疗是否会导致痴呆？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d2293235fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710296, encodeId=7d981e1029600, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=BJH：地塞米松介导的 Notch 信号抑制阻断了白血病和间充质基质细胞的相互作用, objectType=article, longId=220921, objectId=b90f2209211b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b90f2209211b, replyNumber=0, likeNumber=124, createdTime=2022-10-09, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b90f2209211b, moduleTitle=BJH：地塞米松介导的 Notch 信号抑制阻断了白血病和间充质基质细胞的相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b90f2209211b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710305, encodeId=c5ea1e10305c5, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Arthritis：白介素1受体相关激酶4抑制剂PF-06650833阻断风湿病临床前模型研究, objectType=article, longId=301324, objectId=195d301324f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195d301324f5, replyNumber=0, likeNumber=100, createdTime=2022-05-18, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195d301324f5, moduleTitle=Arthritis：白介素1受体相关激酶4抑制剂PF-06650833阻断风湿病临床前模型研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=195d301324f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710277, encodeId=103d1e10277fa, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Gut：中国研究发现暴露于替诺福韦母婴阻断治疗的胎儿长期安全性良好, objectType=article, longId=211274, objectId=c6472112e44b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6472112e44b, replyNumber=0, likeNumber=109, createdTime=2022-01-20, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6472112e44b, moduleTitle=Gut：中国研究发现暴露于替诺福韦母婴阻断治疗的胎儿长期安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6472112e44b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710293, encodeId=ec031e10293bb, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, objectType=article, longId=219773, objectId=a363219e736a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a363219e736a, replyNumber=0, likeNumber=119, createdTime=2022-10-09, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a363219e736a, moduleTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a363219e736a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710284, encodeId=85301e1028459, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Science Tranlational Medicine：为肿瘤免疫疗法“保驾护航”，中美科学家发布全新癌症阻断联合疗法！, objectType=article, longId=213643, objectId=82402136432c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82402136432c, replyNumber=0, likeNumber=111, createdTime=2021-12-23, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82402136432c, moduleTitle=Science Tranlational Medicine：为肿瘤免疫疗法“保驾护航”，中美科学家发布全新癌症阻断联合疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82402136432c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710287, encodeId=1f1c1e1028749, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Front Oncol：免疫检查点阻断治疗转移性肾细胞癌患者在临床结果方面的种族差异, objectType=article, longId=214306, objectId=a51f214306eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a51f214306eb, replyNumber=0, likeNumber=131, createdTime=2022-05-24, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a51f214306eb, moduleTitle=Front Oncol：免疫检查点阻断治疗转移性肾细胞癌患者在临床结果方面的种族差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a51f214306eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710298, encodeId=c7761e1029857, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Commun：激动性CD40疗法会损害胶质瘤对检查点阻断的反应性, objectType=article, longId=292032, objectId=e11629203242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11629203242, replyNumber=0, likeNumber=109, createdTime=2022-01-19, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11629203242, moduleTitle=Nat Commun：激动性CD40疗法会损害胶质瘤对检查点阻断的反应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e11629203242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710289, encodeId=2f291e10289fe, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=2021年9月11日简报：新冠肺炎重症和死亡可能与自身阻断Ⅰ型干扰素作用的抗体有关；地塞米松不适用于预防新冠肺炎, objectType=article, longId=216964, objectId=521621696446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=521621696446, replyNumber=0, likeNumber=112, createdTime=2021-10-05, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=521621696446, moduleTitle=2021年9月11日简报：新冠肺炎重症和死亡可能与自身阻断Ⅰ型干扰素作用的抗体有关；地塞米松不适用于预防新冠肺炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=521621696446)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻断

2020-05-29

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Crit Care：急性呼吸窘迫综合征(ARDS)的COVID-19患者早期短疗程神经肌肉阻断剂的治疗效果

2022-06-12

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

PLoS Pathog：I型干扰素或能在病毒感染期间阻断机体免疫系统的“失控”

2022-12-14

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

ARD：关于在炎症条件下阻断白细胞介素6受体和白细胞介素6的共识声明：更新

2022-12-01

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

磁珠肝门阻断小发明腔镜肝脏切除好助手

2021-12-25

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

J Clin Oncol：PD-1和CTLA-4双重阻断二线治疗晚期宫颈癌疗效显著

2022-09-13

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效

2022-08-18

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

《细胞》子刊：内外夹击，效果更强！科学家揭示PD-1和TIGIT共同阻断疗法的抗癌机制，共同为CD226解围来激活T细胞抗癌功能

2022-06-03

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

2021年12月9日简报：全球奥密克戎变种亚型出现，难以被检测；辉瑞疫苗对奥密克戎阻断力下降41倍，美国加强针接种速度破记录

2022-07-24

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Br J Dermatol：Brodaluma阻断 IL-17RA可减少化脓性汗腺炎皮肤和血清中的炎症通路

2023-01-08

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Med：黑色素瘤患者与免疫检查点阻断毒性相关的T细胞特征

2022-11-25

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Commum：无惧突变，华人团队揭示外泌体可作为诱饵阻断多种新冠突变株

2022-10-08

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

J Urol：雄激素阻断治疗是否会导致痴呆？

2022-01-14

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

BJH：地塞米松介导的 Notch 信号抑制阻断了白血病和间充质基质细胞的相互作用

2022-10-09

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Arthritis：白介素1受体相关激酶4抑制剂PF-06650833阻断风湿病临床前模型研究

2022-05-18

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Gut：中国研究发现暴露于替诺福韦母婴阻断治疗的胎儿长期安全性良好

2022-01-20

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关

2022-10-09

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Science Tranlational Medicine：为肿瘤免疫疗法“保驾护航”，中美科学家发布全新癌症阻断联合疗法！

2021-12-23

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Front Oncol：免疫检查点阻断治疗转移性肾细胞癌患者在临床结果方面的种族差异

2022-05-24

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Commun：激动性CD40疗法会损害胶质瘤对检查点阻断的反应性

2022-01-19

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

2021年9月11日简报：新冠肺炎重症和死亡可能与自身阻断Ⅰ型干扰素作用的抗体有关；地塞米松不适用于预防新冠肺炎

2021-10-05

科室
- - 订阅+
  - 更多科室
工具
服务